Dr. Andrew von Eschenbach
Hear a personal introduction:
Hi, I'm Dr. Andrew von Eschenbach. I'm the Director of the National Cancer Institute, and I'm a survivor of prostate cancer. We're working hard to find the best possible treatments for all types of cancer. But just discovering new treatments isn't enough. We also need to find the most effective ways to get information about those treatments to the people whose health and lives depend on them. That's what breastcancer.org and the Celebrity Talking Dictionary are helping us to do.
Words recorded by Dr. Andrew von Eschenbach:
- amifostine (brand name: Ethyol)
- Aromasin (chemical name: exemestane)
- ataxia
- bevacizumab (brand name: Avastin)
- clinical series
- clinical study [also called clinical trial]
- clinical trial [also called clinical study]
- clodronate
- computed tomography [also called CT scan, computerized tomography, computerized axial tomography, and CAT scan]
- computerized axial tomography scan [also called CAT scan, computed tomography, CT scan, and computerized tomography]
- computerized tomography [also called computed tomography, CT scan, computerized axial tomography, and CAT scan]
- conventional therapy [also called conventional treatment]
- conventional treatment [also called conventional therapy]
- CT scan [also called computed tomography, computerized tomography, computerized axial tomography, and CAT scan]
- DCIS [also called ductal carcinoma in situ or intraductal carcinoma]
- disease-specific survival
- ductal carcinoma in situ [also called DCIS or intraductal carcinoma]
- Ellence (chemical name: epirubicin)
- epirubicin (brand name: Ellence)
- Ethyol (chemical name: amifostine)
- etiology
- exemestane (brand name: Aromasin)
- Fareston (chemical name: toremifene)
- fentanyl
- intraductal carcinoma [also called DCIS or ductal carcinoma in situ]
- positive axillary lymph nodes
- second cancer
- toremifene (brand name: Fareston)
- unresectable
